Krijan Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1817.00%
(FY 2020)
- Profit 1166.43%
(FY 2020)
- Ebitda 1219.30%
(FY 2020)
- Net Worth 192.40%
(FY 2020)
- Total Assets 146.41%
(FY 2020)
About Krijan Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Egi Yadav and Madhusudhan Jeevaji serve as directors at the Company.
- CIN/LLPIN
U36994KA2019PTC119967
- Company No.
119967
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Krijan Biotech Private Limited offer?
Krijan Biotech Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Bio Insecticides, Fertilizers and Soil Additives, Bio Fertilizers, Plant Growth Promoters, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Bird Food, Poultry & Animal Food, Fish Foods, Fertilizer.
Who are the key members and board of directors at Krijan Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Egi Yadav  | Director | 02-Jan-2019 | Current |
| Madhusudhan Jeevaji | Director | 07-Mar-2019 | Current |
Financial Performance of Krijan Biotech.
Krijan Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1817% increase. The company also saw a substantial improvement in profitability, with a 1166.43% increase in profit. The company's net worth Soared by an impressive increase of 192.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krijan Biotech?
In 2019, Krijan Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Krijan Biotech?
Unlock and access historical data on people associated with Krijan Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krijan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krijan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
